SCHEMBL24933418

SCHEMBL24933418

CS(=O)(=O)CCOc1ccc(-c2cc(C(N)=O)c(=O)[nH]c2C(F)(F)F)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MOGAT2 Q3SYC2 5/20 0.41
SCN9A Q15858 1/20 0.39
CYP2C9 P11712 3/20 0.37
CYP3A4 P08684 1/20 0.36
MAPK1 P28482 1/20 0.36
HSD17B10 Q99714 1/20 0.36
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
HPGD P15428 1/20 0.36
PMP22 Q01453 1/20 0.36
HSD17B1 P14061 4/20 0.36
HSD17B2 P37059 4/20 0.36
CHEK2 O96017 2/20 0.35
PARP1 P09874 2/20 0.35
BRD4 O60885 1/20 0.35
BRD1 O95696 1/20 0.35
BRD2 P25440 1/20 0.35
FFAR4 Q5NUL3 1/20 0.34
PDK2 Q15119 1/20 0.34
XDH P47989 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24933256 0.88 PDK2 (0.43) MOGAT2CYP2C9HSD17B1HSD17B2CHEK2
SCHEMBL24933847 0.86 CHEK1 (0.46) MOGAT2SCN9AHSD17B1HSD17B2CHEK2
SCHEMBL24933416 0.84 HSD17B1 (0.36) MOGAT2SCN9AHSD17B1HSD17B2CHEK2
SCHEMBL24932951 0.84 CHEK1 (0.48) MOGAT2KDM4EALDH1A1CHEK2PARP1
SCHEMBL24932956 0.83 FYN (0.45) SCN9AALDH1A1HSD17B1HSD17B2CHEK2
SCHEMBL24932989 0.82 MOGAT2 (0.37) MOGAT2SCN9ACYP2C9HSD17B1HSD17B2
SCHEMBL24933351 0.82 MAOB (0.41) SCN9APARP1
SCHEMBL24933007 0.82 PPARD (0.44) HSD17B1HSD17B2FFAR4
SCHEMBL24933053 0.81 KDM4E (0.44) CYP2C9KDM4EALDH1A1HSD17B1HSD17B2
SCHEMBL30240760 0.80 MAOB (0.43) HSD17B1HSD17B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4373809-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS Novartis AG (CH) 2024-05-29 EP claimed
CN-117980292-A Substituted pyridone compounds for the treatment of orthomyxoviral infections 诺华股份有限公司 2024-05-03 CN claimed
WO-2023002443-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS NOVARTIS AG (CH) 2023-01-26 WO claimed
EP-4373809-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS Novartis AG (CH) 2024-05-29 EP disclosed
CN-117980292-A Substituted pyridone compounds for the treatment of orthomyxoviral infections 诺华股份有限公司 2024-05-03 CN disclosed
WO-2023002443-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS NOVARTIS AG (CH) 2023-01-26 WO disclosed
WO-2023002443-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS NOVARTIS AG (CH) 2023-01-26 WO disclosed